Annalisa Chiapella

Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi

S. Sacchi, A. Santoro, L. Baldini, 2016, Haematologica.